IBDEI094 ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.4)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=3DEXCISION-BENIGN LESIONS^4^23
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=3DEXCISION-MALIGNANT LESIONS^5^23
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=3DINCISION & DRAINAGE^6^23
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=3DMISCELLANEOUS^7^23
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=3DNAILS^8^23
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=3DSHAVING-EPIDERMAL OR DERMAL LESIONS^9^23
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=3DREPAIR-SIMPLE^10^23
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=3DREPAIR-INTERMEDIATE^11^23
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=3DABRASION w/o INFECTION^1^24
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=3DABRASION w/ INFECTION^2^24
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=3DABSCESS/CELLULITIS^3^24
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=3DACNE^4^24
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=3DALOPEICA^5^24
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=3DBURNS^6^24
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=3DCANDIDIASIS^7^24
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=3DCELLULITIS^8^24
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=3DDERMATITIS^9^24
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=3DDERMATOPHYTOSIS^10^24
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=3DECZEMA^11^24
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=3DEDEMA^12^24
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=3DERYTHEMA^13^24
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=3DEXPOSURE TO HEALTH HAZARDS^14^24
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=3DFOLLICULITIS^15^24
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=3DFURUNCLE^16^24
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=3DGRANULOMA^17^24
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=3DHERPES^35^24
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=3DHISTORY^36^24
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=3DICHTHYOSIS^38^24
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=3DINSECT BITE w/o INFECTION^39^24
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=3DINSECT BITE w/INFECTION^40^24
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=3DKERATOSIS^42^24
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=3DLACERATION^44^24
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=3DLESION^46^24
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=3DLICHENIFICATION^47^24
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=3DLUPUS^48^24
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=3DMELANOMA^50^24
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=3DNAIL DISEASE^53^24
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=3DNEOPLASM-BENIGN^54^24
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=3DNEOPLASM-MALIGNANT^55^24
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=3DNEOPLASM-IN SITU^56^24
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=3DNEOPLASM-OTHER^57^24
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=3DNEURODERMATITIS^58^24
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=3DPEDICULOSIS^61^24
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=3DPITYRIASIS^62^24
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=3DPRURITUS^63^24
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=3DPSORIASIS^64^24
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=3DSTASIS^66^24
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=3DULCER^68^24
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=3DULCER-LOWER EXTREMITY^69^24
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=3DUTICARIA^70^24
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=3DVARICOSE VEINS^71^24
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=3DWOUND^73^24
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=3D"A" MISC DIAGNOSIS^5.1^24
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=3D"B" MISC DIAGNOSIS^6.1^24
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=3D"C" MISC DIAGNOSIS^8.1^24
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=3D"D" MISC DIAGNOSIS^10.1^24
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=3D"E" MISC DIAGNOSIS^14.1^24
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=3D"F" MISC DIAGNOSIS^16.1^24
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=3D"H" MISC DIAGNOSIS^37^24
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=3D"I" MISC DIAGNOSIS^41^24
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=3D"K" MISC DIAGNOSIS^43^24
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=3D"L" MISC DIAGNOSIS^49^24
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=3D"M" MISC DIAGNOSIS^51^24
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=3D"N" MISC DIAGNOSIS^59^24
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=3D"P" MISC DIAGNOSIS^65^24
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=3D"X" MISC DIAGNOSIS^75^24
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=3D"V" MISC DIAGNOSIS^72^24
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=3D"W" MISC DIAGNOSIS^74^24
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=3DAFTERCARE CODES^0^24
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=3D"S" MISC DIAGNOSIS^67^24
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=3DCANCER (NOT MELANOMA)^6.5^24
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=3DBOIL/FURUNCLE^5.5^24
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=3DCHEILITIS^8.03^24
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=3DCYST^8.07^24
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=3DDRUG REACTION^10.02^24
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=3D"G" MISC DIAGNOSIS^17.5^24
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=3DLENTIGO^45^24
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=3D"O" DIAGNOSES^60^24
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=3DPSYCHO CUTEANOUS DERMATITIS^64.5^24
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=3D"R" DIAGNOSES^65.5^24
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=3D"T" DIAGNOSES^67.5^24
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=3DEXFOLIATION DUE TO ERYTHEMA^13.1^24
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=3DNEW PATIENT^2^25
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=3DESTABLISHED PATIENT^1^25
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=3DCONSULTATIONS^3^25
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=3DEYE CODES^4^25
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=3DREFRACTION^1^26
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=3DGLASSES/CONTACT LENSES^2^26
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=3DSPECIAL OPHTHALMIC SERVICES^4^26
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=3DPROCEDURES^5^26
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=3DLASER PROCEDURES^6^26
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=3DREFRACTION^1^27
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=3DORBIT/EYELID/LACRIMAL^8^27
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=3DANTERIOR SEGMENT^6^27
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=3DLENS/CATARACT^4^27
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=3DRETINA/VITREOUS^3^27
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=3DNEUROLOGIC EYE DISEASE^9^27
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=3DSYSTEMIC/TRAUMA/OTHER^10^27
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=3DGLAUCOMA^2^27
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=3DSTRABISMUS^9.5^27
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=3DINFECTIONS^7^27
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=3DLOW VISION/BLINDNESS^11^27
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=3DMOST COMMON & POST OP^0^27
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=3DNEW PATIENT^2^28
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=3DESTABLISHED PATIENT^1^28
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=3DCONSULTATIONS^3^28
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=3DBIOPSY/DEBRIDEMENT^1^29
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=3DI&D/ASPIRATION^3^29
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=3DDESTRUCT-BENIGN/PREMALIG LESIONS^4^29
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=3DRESPIRATORY^5^30
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=3DUROLOGY^9^30
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=3DENT^2^30
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=3DGI^4^30
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=3DPLASTIC SURGERY^7^30
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=3DCARDIOVASCULAR^1^30
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=3DORTHOPEDIC^6^30
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=3DABDOMINAL PAIN^3^30
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=3DAFTERCARE POST SURGERY^0^30
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=3DPOST-OP COMPLICATIONS^2^31
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=3DGENERAL/SIGNS & SYMPTOMS^3^31
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=3DGYN/BREAST^1^31
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=3DMALE BREAST^1.6^31
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=3DBENIGN LESIONS OF SKIN^10^31
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=3DMALIGNANT LESIONS OF SKIN^12^31
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=3DMELANOMA^14^31
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=3DLACERATIONS^16^31
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=3DESOPHAGUS^2^32
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=3DSTOMACH/DUODENUM^3^32
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=3DSMALL BOWEL^4^32
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=3DLARGE BOWEL/RECTUM^1^32
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=3DSYMPTOMS^0^32
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=3DLIVER^6^32
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=3DPANCREAS^7^32
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=3DESOPHAGUS^1^33
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=3DENDOSCOPY^2^33
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=3DFLEX SIGMOIDOSCOPY^3^33
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=3DCOLONOSCOPY^5^33
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=3DERCP^6^33
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=3DG-TUBE^7^33
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=3DMISCELLANEOUS-PROCEDURES^8^33
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=3DIMMUNIZAIONS/INJECTIONS^9^33
